The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Forecasted Market Size Trajectory Of The Assisted Reproductive Technology Market From 2026 To 2030?
The assisted reproductive technology market size has experienced robust expansion in recent years. It is projected to increase from $37.06 billion in 2025 to $40.46 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.2%. The historical growth of this market can be attributed to several factors, including the rising prevalence of infertility, increasing maternal age trends, the expansion of fertility clinics, the availability of assisted reproductive procedures, and the growing social acceptance of ART treatments.
The assisted reproductive technology market is poised for significant expansion in the coming years. It is projected to grow to $56.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.9%. This anticipated growth during the forecast period is primarily fueled by the increasing adoption of precision fertility diagnostics, greater investments in fertility treatment infrastructure, the broadening application of genetic testing, a rising demand for minimally invasive procedures, and increased healthcare spending on reproductive health. Noteworthy trends expected over this period include a wider embrace of advanced embryo screening techniques, an uptick in the use of frozen embryo and egg banking, a growing preference for personalized fertility treatments, the extended use of genetic testing in ART procedures, and a heightened focus on improving treatment success rates.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Important Drivers Are Guiding The Assisted Reproductive Technology Market Growth?
An anticipated increase in infertility incidents is projected to stimulate the assisted reproductive technology market in the foreseeable future. Infertility is characterized by the inability to achieve pregnancy following twelve months of regular, unprotected sexual activity. This condition impacts individuals of both genders and is generally identified when conception does not occur. Treatment for infertility often involves assisted reproductive technology (ART), which encompasses various fertility therapies that involve both a woman’s egg and a man’s sperm. For example, as reported in April 2023 by the World Health Organization (WHO), an international public health body headquartered in Switzerland, millions globally within the reproductive age group are expected to face infertility, consequently impacting their families and wider communities. Worldwide, it is estimated that 1 in 6 adults, representing about 17.5% of the global adult population, struggle with infertility. Consequently, the growing prevalence of infertility acts as a significant catalyst for the expansion of the assisted reproductive technology market.
How Are Segments Identified Within The Assisted Reproductive Technology Market Segment Framework?
The assisted reproductive technology market covered in this report is segmented –
1) By Diagnosis: Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing
2) By Procedure Type: Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking
3) By End-User: Hospitals, Fertility Clinics, Other End-Users
Subsegments:
1) By Hysterosalpingography (HSG): X-ray HSG, Sonohysterography (SHG)
2) By Ovarian Reserve Testing: Follicle Stimulating Hormone (FSH) Testing, Anti-Müllerian Hormone (AMH) Testing, Antral Follicle Count (AFC) via Ultrasound
3) By Genetic Testing: Preimplantation Genetic Testing (PGT), Carrier Screening Tests, Genetic Compatibility Testing
What Trends Are Influencing The Evolution Of The Assisted Reproductive Technology Market?
Leading firms within the assisted reproductive technology market are concentrating on creating sophisticated solutions, such as testing kits based on next-generation sequencing (NGS), with the goal of refining chromosomal analysis, optimizing embryo selection, and boosting the efficacy of fertility interventions. Preimplantation genetic testing utilizing NGS involves research-grade technologies that allow for a thorough evaluation of chromosomal irregularities in embryos, thereby facilitating well-informed choices throughout IVF and ICSI processes. As an illustration, in July 2023, US-based biotechnology firm Thermo Fisher Scientific Inc. introduced two products leveraging next-generation sequencing: the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit, designed to aid preimplantation genetic testing for aneuploidy (PGT-A). These assays, intended for reproductive health laboratories, represent the inaugural research-use offerings of this type and integrate seamlessly with the Ion Torrent Genexus Integrated Sequencer, establishing an efficient operational sequence from sample preparation to aneuploidy examination. PGT-A testing aids in detecting chromosomal defects in embryo specimens, and these innovations aspire to deepen scientific knowledge, elevate pregnancy success rates, and foster healthier results for subsequent generations. The Genexus platform additionally streamlines the investigative process via integrated templating, sequencing, and data analysis, concurrently, the Ion AmpliSeq Polyploidy Panel kit provides improved quality control capabilities to identify contamination, prevent sample errors, and ascertain triploidy in embryos, thereby strengthening technological advancements within the assisted reproductive technology market.
Who Are The Companies Competing Within The Assisted Reproductive Technology Market?
Major companies operating in the assisted reproductive technology market are Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Bloom IVF Centre, Vitrolife AB, FUJIFILM Irvine Scientific Inc., Nidacon International AB, Monash IVF Group Ltd., Cook Medical, INVO Bioscience Inc., Thermo Fisher Scientific Inc., Anecova Sa, Carolinas Fertility Institute, Microm Ltd., Inception Sciences Inc., Progyny Inc., Oxford Gene Technology IP Ltd., IVI-RMA Global, Boston IVF, CARE Fertility Group, Virtus Health, Reproductive Medicine Associates of New York, Shady Grove Fertility, CCRM Fertility, New Hope Fertility Center, Houston Fertility Institute, Pacific Fertility Center, RMA of New Jersey, Sher Fertility Institute, IVF Florida, ORM Fertility, HRC Fertility, Arizona Center for Reproductive Endocrinology & Infertility, San Diego Fertility Center, Fertility Centers of Illinois
Get The Full Assisted Reproductive Technology Market Report:
Which Region Is The Top Contributor To The Assisted Reproductive Technology Market By Share?
Europe was the largest region in the assisted reproductive technology market in 2025. North America was the second-largest region in assisted reproductive technology market. The regions covered in the assisted reproductive technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Assisted Reproductive Technology Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Assisted Reproductive Technology Market 2026, By The Business Research Company
Infertility Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report
Fertility Treatments Market Report 2026
https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report
Fertility Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model